Ausnutria Dairy (China) Co., Ltd. – Trademark Portfolio
Entity Type: 99
Ausnutria Dairy (China) Co., Ltd. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 5 Nice Classification classes. Currently, 1 trademark is registered.
(No. 2 Wangwang East Road
Hexi, Changsha), No. 2 Wangwang East Roa
Showing of trademarks Trademarks
Trademark Classifications
Ausnutria Dairy (China) Co., Ltd.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Ausnutria Dairy (China) Co., Ltd. have?
Ausnutria Dairy (China) Co., Ltd. has 13 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Ausnutria Dairy (China) Co., Ltd. file in?
Ausnutria Dairy (China) Co., Ltd. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Ausnutria Dairy (China) Co., Ltd.'s trademark registration success rate?
Ausnutria Dairy (China) Co., Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.